{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T03:31:50Z","timestamp":1786505510884,"version":"build-2736575974"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"DOI":"10.1186\/s12935-026-04338-8","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T08:53:10Z","timestamp":1780908790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An herbal formula, SH003 alleviates colorectal cancer through dual targeting of adaptive and innate checkpoints PD-L1\/CD47"],"prefix":"10.1186","volume":"26","author":[{"given":"Na-Ra","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Ha","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Hyoun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong-Chan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Hoo","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hi-Joon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Gyu","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil-Dong","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"2","key":"4338_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4143\/crt.2024.253","volume":"56","author":"EH Park","year":"2024","unstructured":"Park EH, Jung KW, Park NJ, Kang MJ, Yun EH, Kim HJ, Kim JE, Kong HJ, Im JS, Seo HG, Community of Population-Based Regional Cancer Registries. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2021. Cancer Res Treat. 2024;56(2):357\u201371. https:\/\/doi.org\/10.4143\/crt.2024.253","journal-title":"Cancer Res Treat"},{"issue":"3","key":"4338_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"4338_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.4240\/wjgs.v15.i4.495","volume":"15","author":"A Kumar","year":"2023","unstructured":"Kumar A, Gautam V, Sandhu A, Rawat K, Sharma A, Saha L. Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review. World J Gastrointest Surg. 2023;15(4):495\u2013519. https:\/\/doi.org\/10.4240\/wjgs.v15.i4.495.","journal-title":"World J Gastrointest Surg"},{"issue":"1","key":"4338_CR4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41420-025-02567-w","volume":"11","author":"K Nakano","year":"2025","unstructured":"Nakano K, Oki E, Yamazaki M, Suzuki M, Kawai S, Fujita T, Kato A, Zaitsu Y, Jogo T, Kato C, Watanabe T, Hashimoto E, Nishime C, Fujii E, Ando K, Nagae G, Harimoto N, Ota M, Saeki H, Aburatani H, Yamazaki T. Colorectal cancer cell line-derived organoid model with stem cell properties captures the regrowing state of residual cancer cells after neoadjuvant chemotherapy. Cell Death Discov. 2025;11(1):282. https:\/\/doi.org\/10.1038\/s41420-025-02567-w.","journal-title":"Cell Death Discov"},{"issue":"1","key":"4338_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12964-023-01430-8","volume":"22","author":"A Kamrani","year":"2024","unstructured":"Kamrani A, Nasiri H, Hassanzadeh A, Ahmadian Heris J, Mohammadinasab R, Sadeghvand S, Sadeghi M, Valedkarimi Z, Hosseinzadeh R, Shomali N, Akbari M. New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses. Cell Commun Signal. 2024;22(1):56. https:\/\/doi.org\/10.1186\/s12964-023-01430-8.","journal-title":"Cell Commun Signal"},{"issue":"8","key":"4338_CR6","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.gastha.2023.09.007","volume":"2","author":"AM Cornista","year":"2023","unstructured":"Cornista AM, Giolito MV, Baker K, Hazime H, Dufait I, Datta J, Khumukcham SS, De Ridder M, Roper J, Abreu MT, Breckpot K, Van der Jeught K. Colorectal Cancer Immunotherapy: State of the Art and Future Directions. Gastro Hep Adv. 2023;2(8):1103\u201319. https:\/\/doi.org\/10.1016\/j.gastha.2023.09.007.","journal-title":"Gastro Hep Adv"},{"issue":"2","key":"4338_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00262-020-02679-5","volume":"70","author":"Y Wang","year":"2021","unstructured":"Wang Y, Ni H, Zhou S, He K, Gao Y, Wu W, Wu M, Wu Z, Qiu X, Zhou Y, Chen B, Pan D, Huang C, Li M, Bian Y, Yang M, Miao L, Liu J. Tumor-selective blockade of CD47 signaling with a CD47\/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity. Cancer Immunol Immunother. 2021;70(2):365\u201376. https:\/\/doi.org\/10.1007\/s00262-020-02679-5.","journal-title":"Cancer Immunol Immunother"},{"key":"4338_CR8","doi-asserted-by":"publisher","unstructured":"Sanmamed MF, Chen L. 2018. A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization. 175 (2), 313\u201326. https:\/\/doi.org\/10.1016\/j.cell.2018.09.035","DOI":"10.1016\/j.cell.2018.09.035"},{"issue":"2","key":"4338_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2009.05.046","volume":"138","author":"S Jaiswal","year":"2009","unstructured":"Jaiswal S, Jamieson CH, Pang WW, Park CY, Chao MP, Majeti R, Traver D, van Rooijen N, Weissman IL. CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis. Cell. 2009;138(2):271\u201385. https:\/\/doi.org\/10.1016\/j.cell.2009.05.046.","journal-title":"Cell"},{"issue":"6","key":"4338_CR10","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1056\/NEJMra1806175","volume":"380","author":"M Li","year":"2019","unstructured":"Li M, Belmonte I, J. C. Organoids - Preclinical Models of Human Disease. N Engl J Med. 2019;380(6):569\u201379. https:\/\/doi.org\/10.1056\/NEJMra1806175.","journal-title":"N Engl J Med"},{"issue":"7330","key":"4338_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature09637","volume":"469","author":"T Sato","year":"2011","unstructured":"Sato T, van Es JH, Snippert HJ, Stange DE, Vries RG, van den Born M, Barker N, Shroyer NF, van de Wetering M, Clevers H. Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts. Nature. 2011;469(7330):415\u20138. https:\/\/doi.org\/10.1038\/nature09637.","journal-title":"Nature"},{"key":"4338_CR12","doi-asserted-by":"publisher","first-page":"113260","DOI":"10.1016\/j.biopha.2022.113260","volume":"152","author":"MH Song","year":"2022","unstructured":"Song MH, Park JW, Kim MJ, Shin YK, Kim SC, Jeong SY, Ku JL. Colon cancer organoids using monoclonal organoids established in four different lesions of one cancer patient reveal tumor heterogeneity and different real-time responsiveness to anti-cancer drugs. Biomed Pharmacother. 2022;152:113260. https:\/\/doi.org\/10.1016\/j.biopha.2022.113260.","journal-title":"Biomed Pharmacother"},{"issue":"6378","key":"4338_CR13","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1126\/science.aao2774","volume":"359","author":"G Vlachogiannis","year":"2018","unstructured":"Vlachogiannis G, Hedayat S, Vatsiou A, Jamin Y, Fern\u00e1ndez-Mateos J, Khan K, Lampis A, Eason K, Huntingford I, Burke R, Rata M, Koh DM, Tunariu N, Collins D, Hulkki-Wilson S, Ragulan C, Spiteri I, Moorcraft SY, Chau I, Rao S, Valeri N. Patient-derived organoids model treatment response of metastatic gastrointestinal cancers. Science. 2018;359(6378):920\u20136. https:\/\/doi.org\/10.1126\/science.aao2774.","journal-title":"Science"},{"key":"4338_CR14","doi-asserted-by":"publisher","first-page":"116086","DOI":"10.1016\/j.jep.2022.116086","volume":"305","author":"Z Li","year":"2023","unstructured":"Li Z, Qi J, Guo T, Li J. Research progress of Astragalus membranaceus in treating peritoneal metastatic cancer. J Ethnopharmacol. 2023;305:116086. https:\/\/doi.org\/10.1016\/j.jep.2022.116086.","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"4338_CR15","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jep.2012.07.019","volume":"143","author":"SJ Park","year":"2012","unstructured":"Park SJ, Jung JM, Lee HE, Lee YW, Kim DH, Kim JM, Hong JG, Lee CH, Jung IH, Cho YB, Jang DS, Ryu JH. The memory ameliorating effects of INM-176, an ethanolic extract of Angelica gigas, against scopolamine- or A\u03b2(1\u201342)-induced cognitive dysfunction in mice. J Ethnopharmacol. 2012;143(2):611\u201320. https:\/\/doi.org\/10.1016\/j.jep.2012.07.019.","journal-title":"J Ethnopharmacol"},{"issue":"2","key":"4338_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jep.2007.09.030","volume":"115","author":"JW Shin","year":"2008","unstructured":"Shin JW, Son JY, Kang JK, Han SH, Cho CK, Son CG. Trichosanthes kirilowii tuber extract induces G2\/M phase arrest via inhibition of tubulin polymerization in HepG2 cells. J Ethnopharmacol. 2008;115(2):209\u201316. https:\/\/doi.org\/10.1016\/j.jep.2007.09.030.","journal-title":"J Ethnopharmacol"},{"key":"4338_CR17","doi-asserted-by":"publisher","first-page":"155926","DOI":"10.1016\/j.phymed.2024.155926","volume":"133","author":"HI Kim","year":"2024","unstructured":"Kim HI, Han Y, Kim MH, Boo M, Cho KJ, Kim HL, Lee IS, Jung JH, Kim W, Um JY, Park J, Ko SG. The multi-herbal decoction SH003 alleviates LPS-induced acute lung injury by targeting inflammasome and extracellular traps in neutrophils. Phytomedicine. 2024;133:155926. . https:\/\/doi.org\/10.1016\/j.phymed.2024.155926","journal-title":"Phytomedicine"},{"issue":"2","key":"4338_CR18","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/foods12020276","volume":"12","author":"NR Han","year":"2023","unstructured":"Han NR, Park HJ, Ko SG, Moon PD. The Protective Effect of a Functional Food Consisting of Astragalus membranaceus, Trichosanthes kirilowii, and Angelica gigas or Its Active Component Formononetin against Inflammatory Skin Disorders through Suppression of TSLP via MDM2\/HIF1\u03b1 Signaling Pathways. Foods. 2023;12(2):276. . https:\/\/doi.org\/10.3390\/foods12020276","journal-title":"Foods"},{"key":"4338_CR19","doi-asserted-by":"publisher","unstructured":"Lee K, Ku JM, Choi YJ, Hwang HH, Jeong M, Kim YG, Kim MJ, Ko SG. Herbal Prescription SH003 Alleviates Docetaxel-Induced Neuropathic Pain in C57BL\/6 Mice. Evid Based Complement Alternat Med. 2021;2021(4120334). https:\/\/doi.org\/10.1155\/2021\/4120334.","DOI":"10.1155\/2021\/4120334"},{"key":"4338_CR20","doi-asserted-by":"publisher","unstructured":"Choi HS, Ku JK, Ko SG, Yun PY. 2025. Anticancer effects of SH003 and its active component Cucurbitacin D on oral cancer cell lines via modulation of EMT and cell viability. Oncol. Res. 33 (5), 1217\u20131227. Nodakenin. https:\/\/doi.org\/10.32604\/or.2025.059791","DOI":"10.32604\/or.2025.059791"},{"issue":"7","key":"4338_CR21","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s00262-025-04064-6","volume":"74","author":"YJ Choi","year":"2025","unstructured":"Choi YJ, Lee SE, Kim D, Lim HI, Choi DK, Park BK, Jeon CY, Ko SG. The combination of SH003 and DTX induces cytotoxic cell infiltration in anti-PD1 resistant lung cancer. Immunol Immunother. 2025;74(7):198. . https:\/\/doi.org\/10.1007\/s00262-025-04064-6","journal-title":"Immunol Immunother"},{"issue":"12","key":"4338_CR22","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.3390\/nu15122790","volume":"15","author":"NR Han","year":"2023","unstructured":"Han NR, Park HJ, Ko SG, Moon PD. The Mixture of Natural Products SH003 Exerts Anti-Melanoma Effects through the Modulation of PD-L1 in B16F10 Cells. Nutrients. 2023;15(12):2790. . https:\/\/doi.org\/10.3390\/nu15122790","journal-title":"Nutrients"},{"key":"4338_CR23","doi-asserted-by":"publisher","first-page":"492173","DOI":"10.1155\/2014\/492173","volume":"2014","author":"YK Choi","year":"2014","unstructured":"Choi YK, Cho SG, Woo SM, Yun YJ, Park S, Shin YC, Ko SG. Herbal extract SH003 suppresses tumor growth and metastasis of MDA-MB-231 breast cancer cells by inhibiting STAT3-IL-6 signaling. Mediators Inflamm. 2014;2014:492173. https:\/\/doi.org\/10.1155\/2014\/492173.","journal-title":"Mediators Inflamm"},{"issue":"3","key":"4338_CR24","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1124\/jpet.112.194613","volume":"342","author":"HK Rim","year":"2012","unstructured":"Rim HK, Cho W, Sung SH, Lee KT. Nodakenin suppresses lipopolysaccharide-induced inflammatory responses in macrophage cells by inhibiting tumor necrosis factor receptor-associated factor 6 and nuclear factor-\u03baB pathways and protects mice from lethal endotoxin shock. J Pharmacol Exp Ther. 2012;342(3):654\u201364. https:\/\/doi.org\/10.1124\/jpet.112.194613.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"4338_CR25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00210-024-03304-3","volume":"398","author":"B Shah","year":"2025","unstructured":"Shah B, Solanki N. Ameliorative effect of nodakenin in combating TNBS-induced ulcerative colitis by suppressing NF\u0199B-mediated NLRP3 inflammasome pathway. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(1):673\u201386. https:\/\/doi.org\/10.1007\/s00210-024-03304-3.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"6","key":"4338_CR26","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.3390\/molecules29061240Molecules","volume":"29","author":"C Liu","year":"2024","unstructured":"Liu C, Chen J, Wang Z, Li Y, Zhang Y, Li G. Nodakenin Ameliorates Ovariectomy-Induced Bone Loss by Regulating Gut Microbiota. 2024;29(6):1240. https:\/\/doi.org\/10.3390\/molecules29061240Molecules.","journal-title":"Molecules"},{"issue":"5","key":"4338_CR27","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/molecules29051078","volume":"29","author":"J Song","year":"2024","unstructured":"Song J, Qin BF, Zhang JJ, Feng QY, Liu GC, Zhao GY, Sun HM. Regulation of the Nur77-P2X7r Signaling Pathway by Nodakenin: A Potential Protective Function against Alcoholic Liver Disease. Molecules. 2024;29(5):1078. https:\/\/doi.org\/10.3390\/molecules29051078.","journal-title":"Molecules"},{"issue":"5","key":"4338_CR28","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.21873\/anticanres.17573","volume":"45","author":"HH Hwang","year":"2025","unstructured":"Hwang HH, Yoo JS, Je JH, Lee HC, Kim TH, Sim YB, Cho KJ, Cho SG, Cheon C, Ko SG. SH003 Inhibits Proliferation and Induces Apoptosis in Colon Cancer Through the RTK-STAT3 Pathway. Anticancer Res. 2025;45(5):1965\u201380. https:\/\/doi.org\/10.21873\/anticanres.17573.","journal-title":"Anticancer Res"},{"key":"4338_CR29","doi-asserted-by":"publisher","first-page":"114734","DOI":"10.1016\/j.intimp.2025.114734","volume":"157","author":"KS Chung","year":"2025","unstructured":"Chung KS, Heo SW, Lee JH, Han HS, Kim GH, Kim YR, Kim MS, Hong JE, Rhee KJ, Lee KT. Protective potential of nodakenin in high-fat diet-mediated colitis-associated cancer: Inhibition of STAT3 activation and Wnt\/\u03b2-catenin pathway, and gut microbiota modulation. Int Immunopharmacol. 2025;157:114734. https:\/\/doi.org\/10.1016\/j.intimp.2025.114734.","journal-title":"Int Immunopharmacol"},{"key":"4338_CR30","doi-asserted-by":"publisher","first-page":"114893","DOI":"10.1016\/j.jep.2021.114893","volume":"285","author":"NR Han","year":"2022","unstructured":"Han NR, Kim KC, Kim JS, Ko SG, Park HJ, Moon PD. The immune-enhancing effects of a mixture of Astragalus membranaceus (Fisch.) Bunge, Angelica gigas Nakai, and Trichosanthes Kirilowii (Maxim.) or its active constituent nodakenin. J Ethnopharmacol. 2022;285:114893. https:\/\/doi.org\/10.1016\/j.jep.2021.114893.","journal-title":"J Ethnopharmacol"},{"key":"4338_CR31","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.ijbiomac.2014.08.057","volume":"72","author":"L Liu","year":"2015","unstructured":"Liu L, Shen J, Zhao C, Wang X, Yao J, Gong Y, Yang X. Dietary Astragalus polysaccharide alleviated immunological stress in broilers exposed to lipopolysaccharide. Int J Biol Macromol. 2015;72:624\u201332. https:\/\/doi.org\/10.1016\/j.ijbiomac.2014.08.057.","journal-title":"Int J Biol Macromol"},{"issue":"11","key":"4338_CR32","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s10068-023-01281-6","volume":"32","author":"J Jeong","year":"2023","unstructured":"Jeong J, Lim MK, Han EH, Lee SH, Lee S. Immune-enhancement effects of Angelica gigas Nakai extracts via MAPK\/NF-\u0199B signaling pathways in cyclophosphamide-induced immunosuppressed mice. Food Sci Biotechnol. 2023;32(11):1573\u201384. https:\/\/doi.org\/10.1007\/s10068-023-01281-6.","journal-title":"Food Sci Biotechnol"},{"issue":"1","key":"4338_CR33","doi-asserted-by":"publisher","first-page":"25526","DOI":"10.1038\/s41598-024-76737-8","volume":"14","author":"SC Kim","year":"2024","unstructured":"Kim SC, Kim MJ, Park JW, Shin YK, Jeong SY, Kim S, Ku JL. Effects of simulated microgravity on colorectal cancer organoids growth and drug response. Sci Rep. 2024;14(1):25526. https:\/\/doi.org\/10.1038\/s41598-024-76737-8","journal-title":"Sci Rep"},{"issue":"5","key":"4338_CR34","doi-asserted-by":"publisher","first-page":"e2103360","DOI":"10.1002\/advs.202103360","volume":"9","author":"SC Kim","year":"2022","unstructured":"Kim SC, Park JW, Seo HY, Kim M, Park JH, Kim GH, Lee JO, Shin YK, Bae JM, Koo BK, Jeong SY, Ku JL. Multifocal Organoid Capturing of Colon Cancer Reveals Pervasive Intratumoral Heterogenous Drug Responses. Adv Sci (Weinh). 2022;9(5):e2103360. https:\/\/doi.org\/10.1002\/advs.202103360.","journal-title":"Adv Sci (Weinh)"},{"issue":"12","key":"4338_CR35","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"issue":"8018","key":"4338_CR36","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41586-024-07529-3","volume":"630","author":"JE Bader","year":"2024","unstructured":"Bader JE, Wolf MM, Lupica-Tondo GL, Madden MZ, Reinfeld BI, Arner EN, Hathaway ES, Steiner KK, Needle GA, Hatem Z, Landis MD, Faneuff EE, Blackman A, Wolf EM, Cottam MA, Ye X, Bates ME, Smart K, Wang W, Pinheiro LV, Rathmell JC. Obesity induces PD-1 on macrophages to suppress anti-tumour immunity. Nature. 2024;630(8018):968\u201375. https:\/\/doi.org\/10.1038\/s41586-024-07529-3.","journal-title":"Nature"},{"issue":"1","key":"4338_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12964-020-00545-6","volume":"18","author":"W Chen","year":"2020","unstructured":"Chen W, Liang JL, Zhou K, Zeng QL, Ye JW, Huang MJ. Effect of CIP2A and its mechanism of action in the malignant biological behavior of colorectal cancer. Cell Commun Signal. 2020;18(1):67. https:\/\/doi.org\/10.1186\/s12964-020-00545-6.","journal-title":"Cell Commun Signal"},{"issue":"2","key":"4338_CR38","first-page":"379","volume":"12","author":"MQ Liang","year":"2020","unstructured":"Liang MQ, Yu FQ, Chen C. C-Myc regulates PD-L1 expression in esophageal squamous cell carcinoma. Am J Transl Res. 2020;12(2):379\u201388.","journal-title":"Am J Transl Res"},{"key":"4338_CR39","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12967-014-0226-x","volume":"12","author":"J Wang","year":"2014","unstructured":"Wang J, Ma X, Jones HM, Chan LL, Song F, Zhang W, Bae-Jump VL, Zhou C. Evaluation of the antitumor effects of c-Myc-Max heterodimerization inhibitor 100258-F4 in ovarian cancer cells. J Transl Med. 2014;12:226. https:\/\/doi.org\/10.1186\/s12967-014-0226-x.","journal-title":"J Transl Med"},{"issue":"24","key":"4338_CR40","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.3390\/nu16244415","volume":"16","author":"A Kim","year":"2024","unstructured":"Kim A, Lee EJ, Han JH, Chung HS. Caryophylli Cortex Suppress PD-L1 Expression in Cancer Cells and Potentiates Anti-Tumor Immunity in a Humanized PD-1\/PD-L1 Knock-In MC-38 Colon Cancer Mouse Model. Nutrients. 2024;16(24):4415. . https:\/\/doi.org\/10.3390\/nu16244415","journal-title":"Nutrients"},{"issue":"5","key":"4338_CR41","doi-asserted-by":"publisher","first-page":"e00674","DOI":"10.1128\/IAI.00674-17","volume":"86","author":"JM Sahler","year":"2018","unstructured":"Sahler JM, Eade CR, Altier C, March JC. Salmonella enterica Serovar Typhimurium Increases Functional PD-L1 Synergistically with Gamma Interferon in Intestinal Epithelial Cells via Salmonella Pathogenicity Island 2. Infect Immun. 2018;86(5):e00674\u201317. https:\/\/doi.org\/10.1128\/IAI.00674-17.","journal-title":"Infect Immun"},{"key":"4338_CR42","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ymeth.2025.01.012","volume":"235","author":"X Bian","year":"2025","unstructured":"Bian X, Chen S, Liu W. Ins-ATP: Deep estimation of ATP for organoid based on high throughput microscope images. Methods. 2025;235:34\u201344. https:\/\/doi.org\/10.1016\/j.ymeth.2025.01.012.","journal-title":"Methods"},{"issue":"6282","key":"4338_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1126\/science.aac9935","volume":"352","author":"SC Casey","year":"2016","unstructured":"Casey SC, Tong L, Li Y, Do R, Walz S, Fitzgerald KN, Gouw AM, Baylot V, G\u00fctgemann I, Eilers M, Felsher DW. MYC regulates the antitumor immune response through CD47 and PD-L1. Science. 2016;352(6282):227\u201331. https:\/\/doi.org\/10.1126\/science.aac9935.","journal-title":"Science"},{"issue":"48","key":"4338_CR44","doi-asserted-by":"publisher","first-page":"18390","DOI":"10.3748\/wjg.v20.i48.18390","volume":"20","author":"OA Al Obeed","year":"2014","unstructured":"Al Obeed OA, Alkhayal KA, Sheikh A, Zubaidi A, Vaali-Mohammed AM, Boushey MA, Mckerrow R, Abdulla JH, M. H. Increased expression of tumor necrosis factor-\u03b1 is associated with advanced colorectal cancer stages. World J Gastroenterol. 2014;20(48):18390\u20136. https:\/\/doi.org\/10.3748\/wjg.v20.i48.18390.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"4338_CR45","doi-asserted-by":"publisher","first-page":"e31393","DOI":"10.7759\/cureus.31393","volume":"14","author":"S Balasubramanian","year":"2022","unstructured":"Balasubramanian S, Priyathersini N, Johnson T. Expression of Vascular Endothelial Growth Factor (VEGF) in Colorectal Adenoma and Carcinoma in a Tertiary Care Center. Cureus. 2022;14(11):e31393. https:\/\/doi.org\/10.7759\/cureus.31393.","journal-title":"Cureus"},{"key":"4338_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1476-4598-11-87","volume":"11","author":"Y Li","year":"2012","unstructured":"Li Y, Wang L, Pappan L, Galliher-Beckley A, Shi J. IL-1\u03b2 promotes stemness and invasiveness of colon cancer cells through Zeb1 activation. Mol Cancer. 2012;11:87. https:\/\/doi.org\/10.1186\/1476-4598-11-87.","journal-title":"Mol Cancer"},{"key":"4338_CR47","doi-asserted-by":"publisher","first-page":"14802","DOI":"10.1038\/ncomms14802","volume":"8","author":"PA Betancur","year":"2017","unstructured":"Betancur PA, Abraham BJ, Yiu YY, Willingham SB, Khameneh F, Zarnegar M, Kuo AH, McKenna K, Kojima Y, Leeper NJ, Ho P, Gip P, Swigut T, Sherwood RI, Clarke MF, Somlo G, Young RA, Weissman IL. A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer. Nat Commun. 2017;8:14802. https:\/\/doi.org\/10.1038\/ncomms14802.","journal-title":"Nat Commun"},{"issue":"3","key":"4338_CR48","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/abt\/tbaf012","volume":"8","author":"C Wang","year":"2025","unstructured":"Wang C, Huang H, Song Z, Li Z, Huang J, Cao L, Wu Z, Pan J, Chen X, Shen X. A novel bispecific antibody CVL006 superior to AK112 for dual targeting of PD-L1 and VEGF in cancer therapy. Antib Ther. 2025;8(3):189\u201396. . https:\/\/doi.org\/10.1093\/abt\/tbaf012","journal-title":"Antib Ther"},{"issue":"2","key":"4338_CR49","doi-asserted-by":"publisher","first-page":"e242","DOI":"10.1002\/mco2.242","volume":"4","author":"C Xu","year":"2023","unstructured":"Xu C, Xia Y, Zhang BW, Drokow EK, Li HY, Xu S, Wang Z, Wang SY, Jin P, Fang T, Xiong XM, Huang P, Jin N, Tan JH, Zhong Q, Chen YX, Zhang Q, Fang Y, Ye F, Gao QL. Macrophages facilitate tumor cell PD-L1 expression via an IL-1\u03b2-centered loop to attenuate immune checkpoint blockade. MedComm. 2023;4(2):e242. https:\/\/doi.org\/10.1002\/mco2.242.","journal-title":"MedComm"},{"issue":"1","key":"4338_CR50","doi-asserted-by":"publisher","first-page":"1929005","DOI":"10.1080\/2162402X.2021.1929005","volume":"10","author":"X Zhang","year":"2021","unstructured":"Zhang X, Wang S, Zhu Y, Zhang M, Zhao Y, Yan Z, Wang Q, Li X. Double-edged effects of interferons on the regulation of cancer-immunity cycle. Oncoimmunology. 2021;10(1):1929005. https:\/\/doi.org\/10.1080\/2162402X.2021.1929005.","journal-title":"Oncoimmunology"},{"key":"4338_CR51","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.17179\/excli2025-8617","volume":"24","author":"J Cui","year":"2025","unstructured":"Cui J, Zhang Y, Yang L. IFN-gamma in the tumor microenvironment: dual roles in cancer progression and therapy. EXCLI J. 2025;24:1352\u201371. https:\/\/doi.org\/10.17179\/excli2025-8617.","journal-title":"EXCLI J"},{"issue":"9","key":"4338_CR52","doi-asserted-by":"publisher","first-page":"101162","DOI":"10.1016\/j.tranon.2021.101162","volume":"14","author":"ZH Ye","year":"2021","unstructured":"Ye ZH, Jiang XM, Huang MY, Xu YL, Chen YC, Yuan LW, Huang CY, Yu WB, Chen X, Lu JJ. Regulation of CD47 expression by interferon-gamma in cancer cells. Transl Oncol. 2021;14(9):101162. https:\/\/doi.org\/10.1016\/j.tranon.2021.101162.","journal-title":"Transl Oncol"},{"key":"4338_CR53","doi-asserted-by":"publisher","first-page":"1022129","DOI":"10.3389\/fphar.2022.1022129","volume":"13","author":"L Guo","year":"2022","unstructured":"Guo L, Tang X, Wong SW, Guo A, Lin Y, Kwok HF. Regulation of IFN-\u03b3-mediated PD-L1 expression by MYC in colorectal cancer with wild-type KRAS and TP53 and its clinical implications. Front Pharmacol. 2022;13:1022129. https:\/\/doi.org\/10.3389\/fphar.2022.1022129.","journal-title":"Front Pharmacol"},{"key":"4338_CR54","doi-asserted-by":"publisher","first-page":"216798","DOI":"10.1016\/j.canlet.2024.216798","volume":"588","author":"Y Tang","year":"2024","unstructured":"Tang Y, Wei J, Ge X, Yu C, Lu W, Qian Y, Yang H, Fu D, Fang Y, Zhou X, Wang Z, Xiao Q, Ding K. Intratumoral injection of interferon gamma promotes the efficacy of anti-PD1 treatment in colorectal cancer. Cancer Lett. 2024;588:216798. https:\/\/doi.org\/10.1016\/j.canlet.2024.216798.","journal-title":"Cancer Lett"},{"key":"4338_CR55","doi-asserted-by":"publisher","first-page":"584626","DOI":"10.3389\/fimmu.2020.584626","volume":"11","author":"F Antonangeli","year":"2020","unstructured":"Antonangeli F, Natalini A, Garassino MC, Sica A, Santoni A, Di Rosa F. Regulation of PD-L1 Expression by NF-\u03baB in Cancer. Front Immunol. 2020;11:584626. https:\/\/doi.org\/10.3389\/fimmu.2020.584626.","journal-title":"Front Immunol"},{"issue":"12","key":"4338_CR56","doi-asserted-by":"publisher","first-page":"100862","DOI":"10.1016\/j.tranon.2020.100862","volume":"13","author":"CY Huang","year":"2020","unstructured":"Huang CY, Ye ZH, Huang MY, Lu JJ. Regulation of CD47 expression in cancer cells. Transl Oncol. 2020;13(12):100862. https:\/\/doi.org\/10.1016\/j.tranon.2020.100862.","journal-title":"Transl Oncol"},{"issue":"3","key":"4338_CR57","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1002\/1521-4141(200203)32:3634::3.0.CO;2-9","volume":"32","author":"L Carter","year":"2002","unstructured":"Carter L, Fouser LA, Jussif J, Fitz L, Deng B, Wood CR, Collins M, Honjo T, Freeman GJ, Carreno BM. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol. 2002;32(3):634\u201343. https:\/\/doi.org\/10.1002\/1521-4141(200203)32:3634::3.0.CO;2-9.","journal-title":"Eur J Immunol"},{"issue":"11","key":"4338_CR58","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.it.2023.09.003","volume":"44","author":"V Niederlova","year":"2023","unstructured":"Niederlova V, Tsyklauri O, Kovar M, Stepanek O. IL-2-driven CD8\u2009+\u2009T cell phenotypes: implications for immunotherapy. Trends Immunol. 2023;44(11):890\u2013901. https:\/\/doi.org\/10.1016\/j.it.2023.09.003.","journal-title":"Trends Immunol"},{"issue":"526","key":"4338_CR59","doi-asserted-by":"publisher","first-page":"eaap8112","DOI":"10.1126\/scisignal.aap8112","volume":"11","author":"CM Rollings","year":"2018","unstructured":"Rollings CM, Sinclair LV, Brady HJM, Cantrell DA, Ross SH. Interleukin-2 shapes the cytotoxic T cell proteome and immune environment-sensing programs. Sci Signal. 2018;11(526):eaap8112. https:\/\/doi.org\/10.1126\/scisignal.aap8112.","journal-title":"Sci Signal"},{"issue":"33","key":"4338_CR60","doi-asserted-by":"publisher","first-page":"18064","DOI":"10.1021\/acs.analchem.5c02142","volume":"97","author":"X Wang","year":"2025","unstructured":"Wang X, Wang J, Liang C, Xu S. IL-2 and IFN-\u03b3 Secretion of Activated Jurkat T Cells via a Microdroplet-SERS based Single-Cell Immunoassay (Drop-SCIA). Anal Chem. 2025;97(33):18064\u201374. . https:\/\/doi.org\/10.1021\/acs.analchem.5c02142","journal-title":"Anal Chem"},{"issue":"1","key":"4338_CR61","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s12964-024-01555-4","volume":"22","author":"S Jin","year":"2024","unstructured":"Jin S, Wang H, Li Y, Yang J, Li B, Shi P, Zhang X, Zhou X, Zhou X, Niu X, Wu M, Wu Y, Zhai W, Qi Y, Gao Y, Zhao W. Discovery of a novel small molecule as CD47\/SIRP\u03b1 and PD-1\/PD-L1 dual inhibitor for cancer immunotherapy. Cell Commun Signal. 2024;22(1):173. https:\/\/doi.org\/10.1186\/s12964-024-01555-4.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"4338_CR62","doi-asserted-by":"publisher","first-page":"148","DOI":"10.7150\/thno.79367","volume":"13","author":"R Wang","year":"2023","unstructured":"Wang R, Zhang C, Cao Y, Wang J, Jiao S, Zhang J, Wang M, Tang P, Ouyang Z, Liang W, Mao Y, Wang A, Li G, Zhang J, Wang M, Wang S, Gui X. Blockade of dual immune checkpoint inhibitory signals with a CD47\/PD-L1 bispecific antibody for cancer treatment. Theranostics. 2023;13(1):148\u201360. https:\/\/doi.org\/10.7150\/thno.79367.","journal-title":"Theranostics"},{"key":"4338_CR63","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ebiom.2019.03.018","volume":"42","author":"S Lian","year":"2019","unstructured":"Lian S, Xie R, Ye Y, Xie X, Li S, Lu Y, Li B, Cheng Y, Katanaev VL, Jia L. Simultaneous blocking of CD47 and PD-L1 increases innate and adaptive cancer immune responses and cytokine release. EBioMedicine. 2019;42:281\u201395. https:\/\/doi.org\/10.1016\/j.ebiom.2019.03.018.","journal-title":"EBioMedicine"},{"issue":"72","key":"4338_CR64","doi-asserted-by":"publisher","first-page":"eabl9330","DOI":"10.1126\/sciimmunol.abl9330","volume":"7","author":"RC Hsieh","year":"2022","unstructured":"Hsieh RC, Krishnan S, Wu RC, Boda AR, Liu A, Winkler M, Hsu WH, Lin SH, Hung MC, Chan LC, Bhanu KR, Srinivasamani A, De Azevedo RA, Chou YC, DePinho RA, Gubin M, Vilar E, Chen CH, Slay R, Jayaprakash P, Curran MA. ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer. Sci Immunol. 2022;7(72):eabl9330. https:\/\/doi.org\/10.1126\/sciimmunol.abl9330.","journal-title":"Sci Immunol"},{"key":"4338_CR65","doi-asserted-by":"publisher","first-page":"116203","DOI":"10.1016\/j.biopha.2024.116203","volume":"171","author":"JW Cui","year":"2024","unstructured":"Cui JW, Li Y, Yang Y, Yang HK, Dong JM, Xiao ZH, He X, Guo JH, Wang RQ, Dai B, Zhou ZL. Tumor immunotherapy resistance: Revealing the mechanism of PD-1 \/ PD-L1-mediated tumor immune escape. Biomed Pharmacother. 2024;171:116203. https:\/\/doi.org\/10.1016\/j.biopha.2024.116203.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4338_CR66","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12964-023-01043-1","volume":"21","author":"FY Gao","year":"2023","unstructured":"Gao FY, Li XT, Xu K, Wang RT, Guan XX. c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment. Cell Commun Signal. 2023;21(1):28. https:\/\/doi.org\/10.1186\/s12964-023-01043-1.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"4338_CR67","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1186\/s12885-016-2770-7","volume":"16","author":"KS Lee","year":"2016","unstructured":"Lee KS, Kwak Y, Nam KH, Kim DW, Kang SB, Choe G, Kim WH, Lee HS. Favorable prognosis in colorectal cancer patients with co-expression of c-MYC and \u00df-catenin. BMC Cancer. 2016;16(1):730. https:\/\/doi.org\/10.1186\/s12885-016-2770-7.","journal-title":"BMC Cancer"},{"issue":"1","key":"4338_CR68","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","volume":"19","author":"R Dhanasekaran","year":"2022","unstructured":"Dhanasekaran R, Deutzmann A, Mahauad-Fernandez WD, Hansen AS, Gouw AM, Felsher DW. The MYC oncogene - the grand orchestrator of cancer growth and immune evasion. Nat Rev Clin Oncol. 2022;19(1):23\u201336. https:\/\/doi.org\/10.1038\/s41571-021-00549-2.","journal-title":"Nat Rev Clin Oncol"},{"key":"4338_CR69","doi-asserted-by":"publisher","unstructured":"Han H, Jain AD, Truica MI, Izquierdo-Ferrer J, Anker JF, Lysy B, Sagar V, Luan Y, Chalmers ZR, Unno K, Mok H, Vatapalli R, Yoo YA, Rodriguez Y, Kandela I, Parker JB, Chakravarti D, Mishra RK, Schiltz GE, Abdulkadir SA. 2019. Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy. Cancer Cell 36 (5), 483\u2013497.e15. https:\/\/doi.org\/10.1016\/j.ccell.2019.10.001","DOI":"10.1016\/j.ccell.2019.10.001"},{"key":"4338_CR70","doi-asserted-by":"publisher","first-page":"101851","DOI":"10.1016\/j.tranon.2023.101851","volume":"40","author":"X Chen","year":"2024","unstructured":"Chen X, Chen LJ, Peng XF, Deng L, Wang Y, Li JJ, Guo DL, Niu XH. Anti-PD-1\/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations. Transl Oncol. 2024;40:101851. https:\/\/doi.org\/10.1016\/j.tranon.2023.101851.","journal-title":"Transl Oncol"},{"key":"4338_CR71","doi-asserted-by":"publisher","first-page":"118023","DOI":"10.1016\/j.biopha.2025.118023","volume":"186","author":"H Mahaki","year":"2025","unstructured":"Mahaki H, Nobari S, Tanzadehpanah H, Babaeizad A, Kazemzadeh G, Mehrabzadeh M, Valipour A, Yazdinezhad N, Manoochehri H, Yang P, Sheykhhasan M. Targeting VEGF signaling for tumor microenvironment remodeling and metastasis inhibition: Therapeutic strategies and insights. Biomed Pharmacother. 2025;186:118023. https:\/\/doi.org\/10.1016\/j.biopha.2025.118023.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"4338_CR72","doi-asserted-by":"publisher","first-page":"11923","DOI":"10.1038\/s41598-023-39076-8","volume":"13","author":"N Tzuri","year":"2023","unstructured":"Tzuri N, Yegodayev KM, Novoplansky O, Elkabets M, Aharoni A, Papo N. Developing a dual VEGF\/PDL1 inhibitor based on high-affinity scFv heterodimers as an anti-cancer therapeutic strategy. Sci Rep. 2023;13(1):11923. https:\/\/doi.org\/10.1038\/s41598-023-39076-8.","journal-title":"Sci Rep"},{"issue":"4","key":"4338_CR73","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00262-024-03667-9","volume":"73","author":"K Zhang","year":"2024","unstructured":"Zhang K, Xu Y, Chang X, Xu C, Xue W, Ding D, Nie M, Cai H, Xu J, Zhan L, Han J, Cai T, Ju D, Feng L, Zhang X, Yin K. Co-targeting CD47 and VEGF elicited potent anti-tumor effects in gastric cancer. Cancer Immunol Immunother. 2024;73(4):75. https:\/\/doi.org\/10.1007\/s00262-024-03667-9.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"4338_CR74","doi-asserted-by":"publisher","first-page":"3135","DOI":"10.1038\/s41467-022-30722-9","volume":"13","author":"J Betge","year":"2022","unstructured":"Betge J, Rindtorff N, Sauer J, Rauscher B, Dingert C, Gaitantzi H, Herweck F, Srour-Mhanna K, Miersch T, Valentini E, Boonekamp KE, Hauber V, Gutting T, Frank L, Belle S, Gaiser T, Buchholz I, Jesenofsky R, H\u00e4rtel N, Zhan T, Boutros M. The drug-induced phenotypic landscape of colorectal cancer organoids. Nat Commun. 2022;13(1):3135. https:\/\/doi.org\/10.1038\/s41467-022-30722-9.","journal-title":"Nat Commun"},{"issue":"1","key":"4338_CR75","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1038\/s41392-021-00795-x","volume":"6","author":"Y Gao","year":"2021","unstructured":"Gao Y, Bi D, Xie R, Li M, Guo J, Liu H, Guo X, Fang J, Ding T, Zhu H, Cao Y, Xing M, Zheng J, Xu Q, Xu Q, Wei Q, Qin H. Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer. Signal Transduct Target Ther. 2021;6(1):398. https:\/\/doi.org\/10.1038\/s41392-021-00795-x.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"4338_CR76","doi-asserted-by":"publisher","first-page":"1375-86","DOI":"10.1007\/s12015-024-10723-5","volume":"20","author":"G Park","year":"2024","unstructured":"Park G, Rim YA, Sohn Y, Nam Y, Ju JH. Replacing Animal Testing with Stem Cell-Organoids: Advantages and Limitations. Stem Cell Rev Rep. 2024;20(6):1375\u201386. https:\/\/doi.org\/10.1007\/s12015-024-10723-5","journal-title":"Stem Cell Rev Rep"},{"key":"4338_CR77","doi-asserted-by":"publisher","first-page":"115586","DOI":"10.1016\/j.bcp.2023.115586","volume":"213","author":"S Hockney","year":"2023","unstructured":"Hockney S, Parker J, Turner JE, Todd X, Todryk S, Gieling RG, Hilgen G, Simoes DCM, Pal D. Next generation organoid engineering to replace animals in cancer drug testing. Biochem Pharmacol. 2023;213:115586. https:\/\/doi.org\/10.1016\/j.bcp.2023.115586","journal-title":"Biochem Pharmacol"},{"key":"4338_CR78","doi-asserted-by":"publisher","first-page":"156086","DOI":"10.1016\/j.phymed.2024.156086","volume":"135","author":"Y Asahi","year":"2024","unstructured":"Asahi Y, Xu C, Okuno K, Taketomi A, Goel A. The anticancer effects of Aronia berry extract are mediated by Chk1 and p53 in colorectal cancer. Phytomedicine. 2024;135:156086. https:\/\/doi.org\/10.1016\/j.phymed.2024.156086","journal-title":"Phytomedicine"},{"key":"4338_CR79","doi-asserted-by":"publisher","unstructured":"Wang H, Ji Y, Deng S, Qin XY, Ye XT, Sun YY, Che XY, Yang L, Huang CY, Chen Y, Liu YP. SQYC formula improves the efficacy of PD-1 monoclonal antibodies in MSS colorectal cancer by regulating dendritic cell mitophagy via the PINK1-Parkin pathway. Phytomedicine. 2025;138:156388. https:\/\/doi.org\/10.1016\/j.phymed.2025.156388","DOI":"10.1016\/j.phymed.2025.156388"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-026-04338-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04338-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-026-04338-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T03:26:38Z","timestamp":1786505198000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12935-026-04338-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4338"],"URL":"https:\/\/doi.org\/10.1186\/s12935-026-04338-8","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"3 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"282"}}